NO900251L - Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. - Google Patents

Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Info

Publication number
NO900251L
NO900251L NO90900251A NO900251A NO900251L NO 900251 L NO900251 L NO 900251L NO 90900251 A NO90900251 A NO 90900251A NO 900251 A NO900251 A NO 900251A NO 900251 L NO900251 L NO 900251L
Authority
NO
Norway
Prior art keywords
retinoids
treatment
intrinsic
prevention
procedure
Prior art date
Application number
NO90900251A
Other languages
English (en)
Norwegian (no)
Other versions
NO900251D0 (no
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25672393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO900251(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA000588835A external-priority patent/CA1335651C/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO900251D0 publication Critical patent/NO900251D0/no
Publication of NO900251L publication Critical patent/NO900251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO90900251A 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. NO900251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29911989A 1989-01-19 1989-01-19
CA000588835A CA1335651C (en) 1989-01-20 1989-01-20 Method for the treatment or prevention of intrinsically aged skin with retinoids

Publications (2)

Publication Number Publication Date
NO900251D0 NO900251D0 (no) 1990-01-18
NO900251L true NO900251L (no) 1990-07-20

Family

ID=25672393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900251A NO900251L (no) 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Country Status (15)

Country Link
EP (2) EP0815840A3 (de)
JP (1) JP2931349B2 (de)
AT (1) ATE164513T1 (de)
AU (1) AU636595B2 (de)
DE (1) DE69032182T2 (de)
DK (1) DK0379367T3 (de)
ES (1) ES2115590T3 (de)
FI (1) FI114968B (de)
GR (1) GR3026573T3 (de)
IL (1) IL93106A0 (de)
MY (1) MY106263A (de)
NO (1) NO900251L (de)
PH (1) PH27578A (de)
PT (1) PT92905B (de)
SG (1) SG73394A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
WO1995027474A1 (en) 1994-04-12 1995-10-19 Kao Corporation Dermatologic preparation
JPH11509830A (ja) * 1995-03-20 1999-08-31 ビジョン・ファーマシューティカルズ・リミテッド・パートナーシップ 再狭窄を処置する薬剤を製造するためのレチノイドの使用
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
AU737376B2 (en) 1997-02-25 2001-08-16 Regents Of The University Of Michigan, The Methods and compositions for preventing and treating chronological aging in human skin
JP3408258B2 (ja) * 1997-03-11 2003-05-19 ポーラ化成工業株式会社 皮膚状態改善剤の評価方法及び皮膚外用剤の製造方法
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
NZ569535A (en) 2005-12-30 2011-12-22 Revance Therapeutics Inc Arginine heteromers for topical administration
US8541467B2 (en) 2006-08-16 2013-09-24 Action Medicines, S.L. Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
JP5665276B2 (ja) 2008-02-27 2015-02-04 花王株式会社 皮膚老化予防又は改善剤
EP2133066A1 (de) 2008-06-13 2009-12-16 Antonio Puig, S.A. Kosmetische und dermatologische Zusammensetzung mit einer Mischung aus Retinolderivaten und Tocotrienolen
RU2501544C2 (ru) 2008-12-22 2013-12-20 Джонсон Энд Джонсон Конзьюмер Холдингз Франс Композиция и способ лечения патологических состояний кожи
WO2017053778A1 (en) 2015-09-25 2017-03-30 Fuchs Helen Burgwyn Antibacterial and antifungal compounds
RU2753863C2 (ru) * 2016-02-03 2021-08-24 Галдерма Ресерч Энд Девелопмент Новые биароматические соединения пропинила, фармацевтические и косметические композиции, их содержащие, и их применение
CA3077331A1 (en) * 2017-09-28 2019-04-04 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
GB2642547A (en) * 2024-07-12 2026-01-14 Univ Durham Compounds for use in senotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
FR2479819A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Le retinoate de zinc, sa preparation et les compositions topiques le contenant
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
AU5772686A (en) * 1985-04-22 1986-11-18 Avon Products Inc. Composition and method for reducing wrinkles
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
KR950014443B1 (ko) * 1986-07-16 1995-11-28 엠. 클리그만 알버트 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
CA1326633C (en) * 1987-04-06 1994-02-01 Gerd Plewig Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
DE69032182T2 (de) 1998-08-20
PH27578A (en) 1993-08-18
PT92905B (pt) 1995-12-29
EP0379367A2 (de) 1990-07-25
EP0815840A3 (de) 1998-03-04
ES2115590T3 (es) 1998-07-01
EP0379367B1 (de) 1998-04-01
AU4857390A (en) 1990-07-26
DK0379367T3 (da) 1998-10-19
AU636595B2 (en) 1993-05-06
JP2931349B2 (ja) 1999-08-09
GR3026573T3 (en) 1998-07-31
EP0815840A2 (de) 1998-01-07
JPH02288822A (ja) 1990-11-28
EP0379367A3 (de) 1991-04-24
IL93106A0 (en) 1990-11-05
FI114968B (fi) 2005-02-15
DE69032182D1 (de) 1998-05-07
SG73394A1 (en) 2000-06-20
ATE164513T1 (de) 1998-04-15
FI900293A0 (fi) 1990-01-18
PT92905A (pt) 1990-07-31
MY106263A (en) 1995-04-29
NO900251D0 (no) 1990-01-18

Similar Documents

Publication Publication Date Title
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
DK154789A (da) Avendelse af topisk paafoerbare praeparater til behandling af aeldet hud
SE8504967L (sv) Farmaceutisk komposition och forfarande for behandling av kroppen
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
AU6760987A (en) Method of treating alzheimer's disease
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
NO940266L (no) Indre strålingsskade
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
ATE78171T1 (de) Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien.
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
CA2107914A1 (en) Method to profile and treat abnormal cells
GR3036827T3 (en) Method and composition for the treatment of hair loss.
AU2391484A (en) Silanised and anti seborrheic cosmetic compositions
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.